We are live on ! Find out more
CCP

Corient Capital Partners Portfolio holdings

AUM $1.34B
1-Year Est. Return 12.46%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
-12.46%
3 Year Est. Return
+39.22%
5 Year Est. Return
+66.79%
10 Year Est. Return
AUM
$787M
AUM Growth
+$80.8M
Cap. Flow
+$26.5M
Cap. Flow %
3.37%
Top 10 Hldgs %
26.98%
Holding
498
New
39
Increased
268
Reduced
136
Closed
31

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$2.01M
2
MSFT icon
Microsoft
MSFT
+$1.78M
3
ETN icon
Eaton
ETN
+$1.18M
4
DHR icon
Danaher
DHR
+$1.12M
5
HBAN icon
Huntington Bancshares
HBAN
+$1.09M

Sector Composition

Rank Sector Weight
1 Technology 14.98%
2 Financials 12.65%
3 Healthcare 10.27%
4 Industrials 8.01%
5 Consumer Discretionary 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BX icon
226
Blackstone
BX
$104B
$731K 0.09%
13,054
-253
-2% -$13.1K
HRB icon
227
H&R Block
HRB
$5.98B
$730K 0.09%
31,094
-201
-0.6% -$4.83K
VEA icon
228
Vanguard FTSE Developed Markets ETF
VEA
$223B
$729K 0.09%
16,544
+6,263
+61% +$267K
PWR icon
229
Quanta Services
PWR
$84.2B
$725K 0.09%
+17,811
New +$727K
LNC icon
230
Lincoln National
LNC
$7.92B
$723K 0.09%
12,259
-13,763
-53% -$810K
XLE icon
231
State Street Energy Select Sector SPDR ETF
XLE
$39B
$718K 0.09%
+23,906
New +$709K
TSM icon
232
TSMC
TSM
$1.94T
$704K 0.09%
12,125
+1,100
+10% +$58.3K
NLSN
233
DELISTED
Nielsen Holdings plc
NLSN
$700K 0.09%
34,478
-3,093
-8% -$62.9K
COP icon
234
ConocoPhillips
COP
$144B
$690K 0.09%
10,612
+4,685
+79% +$275K
SYK icon
235
Stryker
SYK
$135B
$680K 0.09%
3,242
-2,329
-42% -$483K
AGN
236
DELISTED
Allergan plc
AGN
$678K 0.09%
3,545
+403
+13% +$72.7K
TWTR
237
DELISTED
Twitter, Inc.
TWTR
$677K 0.09%
21,133
-5,511
-21% -$181K
PXD
238
DELISTED
Pioneer Natural Resource Co.
PXD
$676K 0.09%
4,469
+189
+4% +$25.2K
CI icon
239
Cigna
CI
$78.4B
$672K 0.09%
3,286
-88
-3% -$16.1K
FIS icon
240
Fidelity National Information Services
FIS
$24.2B
$660K 0.08%
4,748
+10
+0.2% +$1.34K
FAST icon
241
Fastenal
FAST
$54.8B
$656K 0.08%
35,510
-412
-1% -$7.36K
BDX icon
242
Becton Dickinson
BDX
$46.4B
$640K 0.08%
2,411
+21
+0.9% +$5.24K
DEO icon
243
Diageo
DEO
$49.6B
$637K 0.08%
3,783
+77
+2% +$12.5K
IVE icon
244
iShares S&P 500 Value ETF
IVE
$49.1B
$637K 0.08%
4,900
GPN icon
245
Global Payments
GPN
$24.1B
$634K 0.08%
3,473
+114
+3% +$19.6K
ROP icon
246
Roper Technologies
ROP
$40.4B
$634K 0.08%
1,790
-232
-11% -$80.1K
WM icon
247
Waste Management
WM
$95B
$632K 0.08%
5,544
+150
+3% +$16.9K
BBY icon
248
Best Buy
BBY
$19B
$621K 0.08%
7,070
-1,089
-13% -$83.3K
KEYS icon
249
Keysight
KEYS
$50.7B
$619K 0.08%
6,035
-601
-9% -$61.5K
KMI icon
250
Kinder Morgan
KMI
$70.9B
$611K 0.08%
28,854
+273
+1% +$5.53K

Similar funds

Corient Capital Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Corient Capital Partners held 498 positions worth $787M, up 11% from $706M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Corient Capital Partners deployed $26.5M of net new capital in Q4 2019, opening 39 new positions and adding to 268 existing holdings. Its largest new stake was Huntington Bancshares: 74,119 shares worth $1.12M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 Growth ETF, an estimated $1.15M trimmed.

  • Corient Capital Partners's largest Q4 2019 buy was Huntington Bancshares: 74,119 shares worth $1.12M.
  • Corient Capital Partners added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.01M increase.
  • Corient Capital Partners's biggest Q4 2019 reduction was Vanguard S&P 500 Growth ETF, cutting an estimated $1.15M.
  • Corient Capital Partners fully exited Celgene Corp in Q4 2019, selling an estimated $1.97M.
  • Corient Capital Partners's ten largest holdings make up 27% of its $787M portfolio in Q4 2019.
  • Corient Capital Partners opened 39 new positions and closed 31 in Q4 2019.
  • Corient Capital Partners's portfolio value rose 11% quarter-over-quarter to $787M.

Based on Corient Capital Partners's 13F filing for Q4 2019, filed 4 Feb 2020.